The reduction in cardiovascular risk in REDUCE-IT is due to eicosapentaenoic acid in icosapent ethyl

por Steg, Ph Gabriel, Bhatt, Deepak L
Publicado 2021

Heart Rate and Use of Beta-Blockers in Stable Outpatients with Coronary Artery Disease

por Steg, Ph. Gabriel, Ferrari, Roberto, Ford, Ian, Greenlaw, Nicola, Tardif, Jean-Claude, Tendera, Michal, Abergel, Hélène, Fox, Kim M.
Publicado 2012

Use of Anticoagulants and Antiplatelet Agents in Stable Outpatients with Coronary Artery Disease and Atrial Fibrillation. International CLARIFY Registry

por Fauchier, Laurent, Greenlaw, Nicola, Ferrari, Roberto, Ford, Ian, Fox, Kim M., Tardif, Jean-Claude, Tendera, Michal, Steg, Ph. Gabriel
Publicado 2015

Women and men with stable coronary artery disease have similar clinical outcomes: insights from the international prospective CLARIFY registry

por Steg, Ph Gabriel, Greenlaw, Nicola, Tardif, Jean-Claude, Tendera, Michal, Ford, Ian, Kääb, Stefan, Abergel, Hélène, Fox, Kim M., Ferrari, Roberto
Publicado 2012

Effect of alirocumab on cataracts in patients with acute coronary syndromes

por Suc, Gaspard, Schwartz, Gregory G., Goodman, Shaun G., Jukema, J. Wouter, Manvelian, Garen, Poulouin, Yann, Pordy, Robert, Scemama, Michel, Szarek, Michael, Steg, Ph. Gabriel
Publicado 2023

Correction: Effect of alirocumab on cataracts in patients with acute coronary syndromes

por Suc, Gaspard, Schwartz, Gregory G., Goodman, Shaun G., Jukema, J. Wouter, Manvelian, Garen, Poulouin, Yann, Pordy, Robert, Scemama, Michel, Szarek, Michael, Steg, Ph.Gabriel
Publicado 2023

Risk Assessment in Patients With Diabetes With the TIMI Risk Score for Atherothrombotic Disease

por Bergmark, Brian A., Bhatt, Deepak L., Braunwald, Eugene, Morrow, David A., Steg, Ph. Gabriel, Gurmu, Yared, Cahn, Avivit, Mosenzon, Ofri, Raz, Itamar, Bohula, Erin, Scirica, Benjamin M.
Publicado 2018

Pharmacokinetic and Pharmacodynamic Profile of a Novel Phospholipid Aspirin Formulation

por Angiolillo, Dominick J., Prats, Jayne, Deliargyris, Efthymios N., Schneider, David J, Scheiman, James, Kimmelstiel, Carey, Steg, Ph. Gabriel, Alberts, Mark, Rosengart, Todd, Mehran, Roxana, Bhatt, Deepak L.
Publicado 2022

Impact of Icosapent Ethyl on Cardiovascular Risk Reduction in Patients With Heart Failure in REDUCE‐IT

por Selvaraj, Senthil, Bhatt, Deepak L., Steg, Ph. Gabriel, Miller, Michael, Brinton, Eliot A., Jacobson, Terry A., Juliano, Rebecca A., Jiao, Lixia, Tardif, Jean‐Claude, Ballantyne, Christie M.
Publicado 2022

Potential effects of icosapent ethyl on cardiovascular outcomes in cigarette smokers: REDUCE-IT smoking

por Miller, Michael, Bhatt, Deepak L, Steg, Ph Gabriel, Brinton, Eliot A, Jacobson, Terry A, Jiao, Lixia, Tardif, Jean-Claude, Ballantyne, Christie M, Budoff, Matthew, Mason, R Preston
Publicado 2022

Has the frequency of bleeding changed over time for patients presenting with an acute coronary syndrome? The Global Registry of Acute Coronary Events

por Fox, Keith A.A., Carruthers, Kathryn, Steg, Ph. Gabriel, Avezum, Álvaro, Granger, Christopher B., Montalescot, Gilles, Goodman, Shaun G., Gore, Joel M., Quill, Ann L., Eagle, Kim A.
Publicado 2010

RUBY-1: a randomized, double-blind, placebo-controlled trial of the safety and tolerability of the novel oral factor Xa inhibitor darexaban (YM150) following acute coronary syndrom...

por Steg, Ph. Gabriel, Mehta, Shamir R., Jukema, J. Wouter, Lip, Gregory Y.H., Gibson, C. Michael, Kovar, Frantisek, Kala, Petr, Garcia-Hernandez, Alberto, Renfurm, Ronny W., Granger, Christopher B.
Publicado 2011

Comparative Safety and Effectiveness of Oral Anticoagulants in Nonvalvular Atrial Fibrillation: The NAXOS Study

por Van Ganse, Eric, Danchin, Nicolas, Mahé, Isabelle, Hanon, Olivier, Jacoud, Flore, Nolin, Maëva, Dalon, Faustine, Lefevre, Cinira, Cotté, François-Emery, Gollety, Sabrina, Falissard, Bruno, Belhassen, Manon, Steg, Ph. Gabriel
Publicado 2020

Lower mortality following pulmonary adverse events and sepsis with ticagrelor compared to clopidogrel in the PLATO study

por Storey, Robert F., James, Stefan K., Siegbahn, Agneta, Varenhorst, Christoph, Held, Claes, Ycas, Joseph, Husted, Steen E., Cannon, Christopher P., Becker, Richard C., Steg, Ph Gabriel, Åsenblad, Nils, Wallentin, Lars
Publicado 2014

Modifiable risk factors control and its relationship with 1 year outcomes after coronary artery bypass surgery: insights from the REACH registry

por Mehta, Rajendra H., Bhatt, Deepak L., Steg, Ph. Gabriel, Goto, Shinya, Hirsch, Alan T., Liau, Chiau-Suong, Röther, Joachim, Wilson, Peter W.F., Richard, Alain-Jean, Eagle, Kim A., Ohman, E. Magnus
Publicado 2008

Ticagrelor Versus Clopidogrel in Patients With Acute Coronary Syndromes and Chronic Obstructive Pulmonary Disease: An Analysis From the Platelet Inhibition and Patient Outcomes (PL...

por Andell, Pontus, James, Stefan K., Cannon, Christopher P., Cyr, Derek D., Himmelmann, Anders, Husted, Steen, Keltai, Matyas, Koul, Sasha, Santoso, Anwar, Steg, Ph. Gabriel, Storey, Robert F., Wallentin, Lars, Erlinge, David
Publicado 2015

Ticagrelor versus clopidogrel in patients with acute coronary syndromes intended for non-invasive management: substudy from prospective randomised PLATelet inhibition and patient O...

por James, Stefan K, Roe, Matthew T, Cannon, Christopher P, Cornel, Jan H, Horrow, Jay, Husted, Steen, Katus, Hugo, Morais, Joao, Steg, Ph Gabriel, Storey, Robert F, Stevens, Susanna, Wallentin, Lars, Harrington, Robert A
Publicado 2011

Three-year follow-up and event rates in the international REduction of Atherothrombosis for Continued Health Registry

por Alberts, Mark J., Bhatt, Deepak L., Mas, Jean-Louis, Ohman, E. Magnus, Hirsch, Alan T., Röther, Joachim, Salette, Geneviève, Goto, Shinya, Smith, Sidney C., Liau, Chiau-Suong, Wilson, Peter W.F., Steg, Ph. Gabriel
Publicado 2009

Variation in Patient Profiles and Outcomes in US and Non-US Subgroups of the Cangrelor Versus Standard Therapy to Achieve Optimal Management of Platelet Inhibition (CHAMPION) PHOEN...

por Vaduganathan, Muthiah, Harrington, Robert A., Stone, Gregg W., Steg, Ph. Gabriel, Gibson, C. Michael, Hamm, Christian W., Price, Matthew J., Prats, Jayne, Deliargyris, Efthymios N., Mahaffey, Kenneth W., White, Harvey D., Bhatt, Deepak L.
Publicado 2016

Safety and efficacy of dual vs. triple antithrombotic therapy in patients with atrial fibrillation following percutaneous coronary intervention: a systematic review and meta-analys...

por Golwala, Harsh B, Cannon, Christopher P, Steg, Ph Gabriel, Doros, Gheorghe, Qamar, Arman, Ellis, Stephen G, Oldgren, Jonas, ten Berg, Jurrien M, Kimura, Takeshi, Hohnloser, Stefan H, Lip, Gregory Y H, Bhatt, Deepak L
Publicado 2018